The veteran's Hodgkin's disease and non-Hodgkin's lymphoma are in remission, but he continues to experience fatigue as a result of his treatment. His splenectomy is rated at 30 percent due to easy fatigability and risk of future recurrence of other malignancies. The cervical and thoracic degenerative joint disease warrant a 10 percent evaluation.
The deciding factor: The veteran's Hodgkin's disease and non-Hodgkin's lymphoma are in remission, but he continues to experience fatigue as a result of his treatment. His splenectomy is rated at 30 percent due to easy fatigability and risk of future recurrence of other malignancies.
- Claimed conditions
- Hodgkin's disease, Non-Hodgkin's lymphoma diffuse large cell type in the right cervical region and adjacent tonsil
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- November 25, 2002
- Citation
- 0217034
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0217034.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted service connection for Hodgkin's disease, resolving reasonable doubt in the Veteran's favor. The claim for restrictive lung disease was remanded for further development.
- Denied
The Board denied service connection for bilateral hearing loss and various increased rating claims, as well as effective date claims, while remanding the claim for service connection for Hodgkin's disease.
- Remanded (sent back)
The Board remanded the veteran's claims for service connection for obstructive sleep apnea, non-Hodgkin's lymphoma, and Hodgkin's disease. The Board found that the VA did not adequately address the veteran's claimed exposures and symptoms.
- Remanded (sent back)
The Board remanded the Veteran's claims for service connection of b-cell leukemia, Hodgkin's disease, lymphosarcoma, and soft tissue sarcoma due to herbicide exposure. The Veteran served in Vietnam during the period when Agent Orange was used.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.